Addex Therapeutics Short Interest Ratio and Short Volume

Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 200 shares of ADXN short. Learn More on Addex Therapeutics' current short interest.

Addex Therapeutics saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 200 shares, a decrease of 96.0% from the previous total of 5,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Addex Therapeutics: MedAvail Holdings, Inc (1.68%), Fortress Biotech, Inc. (1.80%), Clearside Biomedical, Inc. (3.56%), Wave Life Sciences Ltd. (6.39%), MEI Pharma, Inc. (9.62%), Syros Pharmaceuticals, Inc. (11.38%), Verrica Pharmaceuticals Inc. (14.19%), CymaBay Therapeutics, Inc. (11.89%), 9 Meters Biopharma, Inc. (3.85%), and Taiwan Liposome Company, Ltd. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Square, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks.

Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. Addex Therapeutics' stock is trading down $0.31 today. To short Addex Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Addex Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is June, 30 2021.